Zhejiang Anglikang Pharmaceutical Co. Ltd. (002940) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Anglikang Pharmaceutical Co. Ltd.

Why is Zhejiang Anglikang Pharmaceutical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.31% and Operating profit at -6.58% over the last 5 years

Positive results in Mar 26

NET PROFIT(9M) At CNY 76.67 MM has Grown at 172.44%
ROCE(HY) Highest at 7.96%
RAW MATERIAL COST(Y) Fallen by 1.33% (YoY)

With ROE of 9.14%, it has a very expensive valuation with a 3.86 Price to Book Value

Over the past year, while the stock has generated a return of 212.67%, its profits have fallen by -2.2%
At the current price, the company has a high dividend yield of 0.7

Market Beating performance in long term as well as near term

Along with generating 212.67% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Anglikang Pharmaceutical Co. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Anglikang Pharmaceutical Co. Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Anglikang Pharmaceutical Co. Ltd.

212.67%

2.51

75.71%

China Shanghai Composite

20.36%

1.53

13.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.31%

EBIT Growth (5y)

-6.58%

EBIT to Interest (avg)

71.12

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.63

Tax Ratio

1.73%

Dividend Payout Ratio

40.10%

Pledged Shares

Institutional Holding

ROCE (avg)

13.84%

ROE (avg)

10.46%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.86

EV to EBIT

54.20

EV to EBITDA

35.40

EV to Capital Employed

3.82

EV to Sales

4.21

PEG Ratio

Dividend Yield

0.74%

ROCE (Latest)

7.06%

ROE (Latest)

9.14%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET PROFIT(9M)

At CNY 76.67 MM has Grown at 172.44%

ROCE(HY)

Highest at 7.96%

RAW MATERIAL COST(Y)

Fallen by 1.33% (YoY

-5What is not working for the Company

INTEREST COVERAGE RATIO(Q)

Lowest at 876.23

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.82 times

OPERATING PROFIT(Q)

Lowest at CNY 26.32 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 7.74 %

Here's what is working for Zhejiang Anglikang Pharmaceutical Co. Ltd.

Net Profit

At CNY 76.67 MM has Grown at 172.44%

Year on Year (YoY)

MOJO Watch

Net Profit trend is very positive

Net Profit (CNY MM)

Raw Material Cost

Fallen by 1.33% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Anglikang Pharmaceutical Co. Ltd.

Interest Coverage Ratio

Lowest at 876.23

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 26.32 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 7.74 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 1.82 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio